This could help block the activity of EGFR ligands implicated in cancer and inflammation (e.g., AREG, EREG, [48,49,50,51,52]) without affecting the function of TGFα in protection of the skin and intestinal barrier [13,16,17]. Here, EREG is linked to cancer.